Iambic Therapeutics, Inc.

Today, IAM trades at 13.49 USD.

For broader market analysis, dive into the technicals on the Iambic Therapeutics, Inc. stock price chart and read the latest IAM news:
– Weekly Recap: Intracranial responses and 960 mg dose tolerability
– Iambic Presents Updated Iam1363 Clinical Data At Esmo 2026, Showing Durable Responses With A Favorable Tolerability Profile In Heavily Pretreated Participants With Her2-Driven Cancers
– Iambic Presents Updated IAM1363 Clinical Data at ESMO 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with HER2-Driven Cancers

Markets don't sleep, here's what's going on with IAM at the moment:
– Weekly Recap: Intracranial responses and 960 mg dose tolerability
– Iambic Presents Updated Iam1363 Clinical Data At Esmo 2026, Showing Durable Responses With A Favorable Tolerability Profile In Heavily Pretreated Participants With Her2-Driven Cancers
– Iambic Presents Updated IAM1363 Clinical Data at ESMO 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with HER2-Driven Cancers

See more updates in real-time with our News Flow.

To understand the IAM stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +1.16%
– 1 week — −9.06%
– 1 month — −18.85%

IAM all-time low was 12.39 USD (Oct 30, 2026), and its highest price is 25.00 USD (Oct 16, 2026). Find more dynamics in the Stock Heatmap and on the Iambic Therapeutics, Inc. stock chart.

Iambic Therapeutics, Inc. market capitalization is ‪614.08 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Iambic Therapeutics, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Iambic Therapeutics, Inc. stacks up against other companies

Iambic Therapeutics, Inc. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Iambic Therapeutics, Inc. stocks trade under the symbol IAM.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.

Yes, you can track Iambic Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.

No, Iambic Therapeutics, Inc. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends